Systemic bone-seeking radionuclides for palliation of painful osseous metastases: current concepts

Bone metastases require multidisciplinary treatment, the primary goal of which is to relieve pain and improve quality of life. Among the options available, bone-seeking radioisotopes are attractive because they can treat several symptomatic metastases simultaneously. This therapy may have antitumor...

Full description

Saved in:

Bibliographic Details
Published in:	CA: a cancer journal for clinicians Vol. 48; no. 6; pp. 361 - 374
Main Authors:	Mertens, W. C, Filipczak, L. A, Ben-Josef, E, Davis, L. P, Porter, A. T
Format:	Journal Article
Language:	English
Published:	Bristol Am Cancer Soc 01-11-1998 John Wiley & Sons, Ltd Wiley Subscription Services, Inc
Subjects:	Analgesics - adverse effects Analgesics - therapeutic use Bone and Bones - diagnostic imaging Bone Neoplasms - drug therapy Bone Neoplasms - secondary Bones Cancer Drug Therapy, Combination Humans Pain - drug therapy Palliative Care - methods Radiation Radioisotopes - adverse effects Radioisotopes - therapeutic use Radionuclide Imaging Therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Bone metastases require multidisciplinary treatment, the primary goal of which is to relieve pain and improve quality of life. Among the options available, bone-seeking radioisotopes are attractive because they can treat several symptomatic metastases simultaneously. This therapy may have antitumor efficacy in addition to analgesic properties. Although the ultimate place of systemic radionuclides in the treatment of bone metastases has not been firmly established, some patients clearly benefit from these modalities.
Bibliography:	This article is also available online at http://www.ca‐journal.org . ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	0007-9235 1542-4863
DOI:	10.3322/canjclin.48.6.361